Board of Trustees

Marc Doble

Vice President and General Manager for Amgen’s Biosimilars Business Unit

Doble is Vice President and General Manager for Amgen’s Biosimilars business unit. He is responsible for Amgen’s biosimilars strategy, pipeline, and commercial portfolio. Doble has worked with Amgen for 20 years in a variety of roles, mainly across operations and corporate functions. He began his career as a research scientist at Harvard Medical School and also worked in product development for start-up biotech companies.

Doble was part of the first graduating class at KGI in 2002, earning a masters in business and bioscience. He is the second alumnus to serve on the KGI Board of Trustees.

Doble also earned a chemistry degree from College of the Holy Cross.